noom vs hers glp 1 launches full-page ad in Wall Street Journal advocating for policy changes regarding compounded GLP-1s Noom vs Hims: GLP-1 Programs

GLP1s in higher amounts also act on portions of the brain that suppress appetite and signal satiety (feeling full)

The FDA-approved indications focus on glycemic control in type 2 diabetes and chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, with some products (Wegovy, Saxenda) also approved for certain adolescents

Credentials Breakdown LegitScript Certification Verified LegitScript certification is the industry gold standard for online healthcare providers, and Willows certification shows it meets rigorous standards for safety, compliance, and trustworthy online practices

Enquire Now Frequently Asked Questions GLP-1 Market Size is valued at USD 94.06 Bn in 2025 and is predicted to reach USD 216.12 Bn by the year 2035

Both reads can be true at the same time